Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2007, Article ID 10767, 11 pages
http://dx.doi.org/10.1155/2007/10767
Research Article

Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3,5-dione) Blocks the Chemotaxis of Neutrophils by Inhibiting Signal Transduction through IL-8 Receptors

1Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan
2Department of Surgery II, Faculty of Medicine, University of Miyazaki, Miyazaki-shi, Miyazaki 889-2192, Japan
3Department of Surgery, Kumamoto Rousai Hospital, Yatsushiro 866-8533, Japan

Received 22 October 2006; Revised 24 January 2007; Accepted 5 April 2007

Copyright © 2007 Masafumi Takahashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. P. Sharma, “Antioxidant activity of curcumin and related compounds,” Biochemical Pharmacology, vol. 25, no. 15, pp. 1811–1812, 1976. View at Publisher · View at Google Scholar
  2. K. K. Soudamini and R. Kuttan, “Inhibition of chemical carcinogenesis by curcumin,” Journal of Ethnopharmacology, vol. 27, no. 1-2, pp. 227–233, 1989. View at Publisher · View at Google Scholar
  3. J. C. Baumann, “Effect of chelidonium, curcuma, absinth and Carduus marianus on the bile and pancreatic secretion in liver diseases,” Medizinische Monatsschrift, vol. 29, no. 4, pp. 173–180, 1975. View at Google Scholar
  4. Y. X. Xu, K. R. Pindolia, N. Janakiraman, C. J. Noth, R. A. Chapman, and S. C. Gautam, “Curcumin, a compound with anti-inflammatory and anti oxidant properties, down-regulates chemokine expression in bone marrow stromal cells,” Experimental Hematology, vol. 25, no. 5, pp. 413–422, 1997. View at Google Scholar
  5. J. Miquel, A. Bernd, J. Sempere, J. Díaz-Alperi, and A. Ramírez, “The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review,” Archives of Gerontology and Geriatrics, vol. 34, no. 1, pp. 37–46, 2002. View at Publisher · View at Google Scholar
  6. M.-S. Woo, S.-H. Jung, S.-Y. Kim et al., “Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells,” Biochemical and Biophysical Research Communications, vol. 335, no. 4, pp. 1017–1025, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. Y.-R. Chen and T.-H. Tan, “Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin,” Oncogene, vol. 17, no. 2, pp. 173–178, 1998. View at Publisher · View at Google Scholar · View at PubMed
  8. H. Hidaka, T. Ishiko, T. Furuhashi et al., “Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface: impact on human pancreatic carcinoma cell growth by autocrine regulation,” Cancer, vol. 95, no. 6, pp. 1206–1214, 2002. View at Publisher · View at Google Scholar · View at PubMed
  9. C. Jobin, C. A. Bradham, M. P. Russo et al., “Curcumin blocks cytokine-mediated NF-κB activation and proinflammatory gene expression by inhibiting inhibitory factor I-κB kinase activity,” Journal of Immunology, vol. 163, no. 6, pp. 3474–3483, 1999. View at Google Scholar
  10. S. Singh and B. B. Aggarwal, “Activation of transcription factor NF-κB is suppressed by curcumin (diferulolylmethane),” Journal of Biological Chemistry, vol. 270, no. 42, pp. 24995–25000, 1995. View at Publisher · View at Google Scholar
  11. B. Y. Kang, S. W. Chung, W.-J. Chung, S.-Y. Im, S. Y. Hwang, and T. S. Kim, “Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin,” European Journal of Pharmacology, vol. 384, no. 2-3, pp. 191–195, 1999. View at Publisher · View at Google Scholar
  12. B. Gupta and B. Ghosh, “Curcuma longa inhibits TNF-α induced expression of adhesion molecules on human umbilical vein endothelial cells,” International Journal of Immunopharmacology, vol. 21, no. 11, pp. 745–757, 1999. View at Publisher · View at Google Scholar
  13. P. M. Murphy and H. L. Tiffany, “Cloning of complementary DNA encoding a functional human interleukin-8 receptor,” Science, vol. 253, no. 5025, pp. 1280–1283, 1991. View at Publisher · View at Google Scholar
  14. J. Lee, R. Horuk, G. C. Rice, G. L. Bennett, T. Camerato, and W. I. Wood, “Characterization of two high affinity human interleukin-8 receptors,” Journal of Biological Chemistry, vol. 267, no. 23, pp. 16283–16287, 1992. View at Google Scholar
  15. K. Asagoe, K. Yamamoto, A. Takahashi et al., “Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-α,” Journal of Immunology, vol. 160, no. 9, pp. 4518–4525, 1998. View at Google Scholar
  16. M. Baggiolini, B. Dewald, and B. Moser, “Human chemokines: an update,” Annual Review of Immunology, vol. 15, pp. 675–705, 1997. View at Publisher · View at Google Scholar · View at PubMed
  17. R. Feniger-Barish, M. Ran, A. Zaslaver, and A. Ben-Baruch, “Differential modes of regulation of CXC chemokine-induced internalization and recycling of human CXCR1 and CXCR2,” Cytokine, vol. 11, no. 12, pp. 996–1009, 1999. View at Publisher · View at Google Scholar · View at PubMed
  18. J. J. Rose, J. F. Foley, P. M. Murphy, and S. Venkatesan, “On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2,” Journal of Biological Chemistry, vol. 279, no. 23, pp. 24372–24386, 2004. View at Publisher · View at Google Scholar · View at PubMed
  19. J. Barlic, M. H. Khandaker, E. Mahon et al., “β-arrestins regulate interleukin-8-induced CXCR1 internalization,” Journal of Biological Chemistry, vol. 274, no. 23, pp. 16287–16294, 1999. View at Publisher · View at Google Scholar
  20. A. Chuntharapai and K. J. Kim, “Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor,” Journal of Immunology, vol. 155, no. 5, pp. 2587–2594, 1995. View at Google Scholar
  21. R. M. Richardson, B. C. Pridgen, B. Haribabu, H. Ali, and R. Snyderman, “Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation,” Journal of Biological Chemistry, vol. 273, no. 37, pp. 23830–23836, 1998. View at Publisher · View at Google Scholar
  22. W. Yang, D. Wang, and A. Richmond, “Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction,” Journal of Biological Chemistry, vol. 274, no. 16, pp. 11328–11333, 1999. View at Publisher · View at Google Scholar
  23. M. E. W. Hammond, G. R. Lapointe, P. H. Feucht et al., “IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors,” Journal of Immunology, vol. 155, no. 3, pp. 1428–1433, 1995. View at Google Scholar
  24. M. Bhattacharya, A. V. Babwah, and S. S. G. Ferguson, “Small GTP-binding protein-coupled receptors,” Biochemical Society Transactions, vol. 32, part 6, pp. 1040–1044, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. J. S. Rodman and A. Wandinger-Ness, “Rab GTPases coordinate endocytosis,” Journal of Cell Science, vol. 113, no. 2, pp. 183–192, 2000. View at Google Scholar
  26. M. Wilcke, L. Johannes, T. Galli, V. Mayau, B. Goud, and J. Salamero, “Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network,” Journal of Cell Biology, vol. 151, no. 6, pp. 1207–1220, 2000. View at Publisher · View at Google Scholar
  27. G.-H. Fan, L. A. Lapierre, J. R. Goldenring, J. Sai, and A. Richmond, “Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis,” Molecular Biology of the Cell, vol. 15, no. 5, pp. 2456–2469, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. G.-H. Fan, L. A. Lapierre, J. R. Goldenring, and A. Richmond, “Differential regulation of CXCR2 trafficking by Rab GTPases,” Blood, vol. 101, no. 6, pp. 2115–2124, 2003. View at Publisher · View at Google Scholar · View at PubMed
  29. W. Falk, R. H. Goodwin Jr., and E. J. Leonard, “A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration,” Journal of Immunological Methods, vol. 33, no. 3, pp. 239–247, 1980. View at Publisher · View at Google Scholar
  30. S. Ali, A. C. V. Palmer, S. J. Fritchley, Y. Maley, and J. A. Kirby, “Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis,” Biochemical Journal, vol. 358, no. 3, pp. 737–745, 2001. View at Publisher · View at Google Scholar
  31. B. J. Mounho, D. R. Davila, and S. W. Burchiel, “Characterization of intracellular calcium responses produced by polycyclic aromatic hydrocarbons in surface marker-defined human peripheral blood mononuclear cells,” Toxicology and Applied Pharmacology, vol. 145, no. 2, pp. 323–330, 1997. View at Publisher · View at Google Scholar · View at PubMed
  32. S. W. Burchiel, B. S. Edwards, F. W. Kuckuck et al., “Analysis of free intracellular calcium by flow cytometry: multiparameter and pharmacologic applications,” Methods, vol. 21, no. 3, pp. 221–230, 2000. View at Publisher · View at Google Scholar · View at PubMed
  33. L. J. Picker, M. K. Singh, Z. Zdraveski et al., “Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry,” Blood, vol. 86, no. 4, pp. 1408–1419, 1995. View at Google Scholar
  34. S. Suzuki, M. Kobayashi, K. Chiba et al., “Autocrine production of epithelial cell-derived neutrophil attractant-78 induced by granulocyte colony-stimulating factor in neutrophils,” Blood, vol. 99, no. 5, pp. 1863–1865, 2002. View at Publisher · View at Google Scholar
  35. I. Sabroe, T. J. Williams, C. A. Hébert, and P. D. Collins, “Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation,” Journal of Immunology, vol. 158, no. 3, pp. 1361–1369, 1997. View at Google Scholar
  36. R. M. Richardson, R. J. Marjoram, L. S. Barak, and R. Snyderman, “Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation,” Journal of Immunology, vol. 170, no. 6, pp. 2904–2911, 2003. View at Google Scholar
  37. D. Wu, G. J. LaRosa, and M. I. Simon, “G protein-coupled signal transduction pathways for interleukin-8,” Science, vol. 261, no. 5117, pp. 101–103, 1993. View at Publisher · View at Google Scholar
  38. R. H. Moore, E. E. Millman, E. Alpizar-Foster, W. Dai, and B. J. Knoll, “Rab11 regulates the recycling and lysosome targeting of β2-adrenergic receptors,” Journal of Cell Science, vol. 117, no. 15, pp. 3107–3117, 2004. View at Publisher · View at Google Scholar · View at PubMed
  39. L. A. Volpicelli, J. J. Lah, G. Fang, J. R. Goldenring, and A. I. Levey, “Rab11a and myosin Vb regulate recycling of the M4 muscarinic acetylcholine receptor,” Journal of Neuroscience, vol. 22, no. 22, pp. 9776–9784, 2002. View at Google Scholar
  40. S. Reddy and B. B. Aggarwal, “Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase,” FEBS Letters, vol. 341, no. 1, pp. 19–22, 1994. View at Publisher · View at Google Scholar
  41. S. Anuchapreeda, P. Leechanachai, M. M. Smith, S. V. Ambudkar, and P.-N. Limtrakul, “Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells,” Biochemical Pharmacology, vol. 64, no. 4, pp. 573–582, 2002. View at Publisher · View at Google Scholar
  42. H. Ligeret, S. Barthelemy, R. Zini, J.-P. Tillement, S. Labidalle, and D. Morin, “Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pore,” Free Radical Biology and Medicine, vol. 36, no. 7, pp. 919–929, 2004. View at Publisher · View at Google Scholar · View at PubMed
  43. T. Atsumi, Y. Murakami, K. Shibuya, K. Tonosaki, and S. Fujisawa, “Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression, by curcumin and its analog, α-diisoeugenol,” Anticancer Research, vol. 25, no. 6B, pp. 4029–4036, 2005. View at Google Scholar
  44. C. A. Dinarello, J. A. Gelfand, and S. M. Wolff, “Anticytokine strategies in the treatment of the systemic inflammatory response syndrome,” Journal of the American Medical Association, vol. 269, no. 14, pp. 1829–1835, 1993. View at Publisher · View at Google Scholar